A103D (p.Ala103Asp) variant of CASQ2 (Calsequestrin-2)
A103D (p.Ala103Asp) in CASQ2 (Calsequestrin-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
A103D (p.Ala103Asp) variant details
- p.Ala103Asp
- NCI-TCGA Cosmic COSV5477
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available